A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)
Clinical trial NCT05936281 · COMPLETED
Trial details
- NCT number
- NCT05936281
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2024-01-19
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.